Maxona Pharmaceuticals Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 1

Employees

  • Latest Deal Type
  • Series C
  • (In Progress)

  • Latest Deal Amount
  • $12M

  • Investors
  • 1

Maxona Pharmaceuticals General Information

Description

Operator of a pharmaceutical company intended to develop novel therapeutics for the treatment of moderate to severe pain without any side effects. The company leverages technology to develop non-opioid, non-NSAID, and non-CBD analgesia using nefopam, a centrally acting agent that exerts antinociceptive effects via a triple neurotransmitter mechanism of action, enabling patients to get an opioid-free route for treating pain.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 101 Lindenwood Drive
  • Suite 225
  • Malvern, PA 19355
  • United States
+1 (484)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Corporate Office
  • 101 Lindenwood Drive
  • Suite 225
  • Malvern, PA 19355
  • United States
+1 (484)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Maxona Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series C) 04-Jun-2025 $12M In Progress Clinical Trials - Phase 1
2. Later Stage VC (Series B) 22-Apr-2024 Completed Pre-Clinical Trials
1. Later Stage VC (Series A) 05-May-2021 $10M $10M Completed Pre-Clinical Trials
To view Maxona Pharmaceuticals’s complete valuation and funding history, request access »

Maxona Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 10,000,000 $0.001000 $1 $1 1x $1 24.81%
To view Maxona Pharmaceuticals’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Maxona Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a pharmaceutical company intended to develop novel therapeutics for the treatment of moderate to severe pain
Drug Discovery
Malvern, PA
1 As of 2026

Cary, NC
 

Stamford, CT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Maxona Pharmaceuticals Competitors (5)

One of Maxona Pharmaceuticals’s 5 competitors is Heron Therapeutics, a Formerly VC-backed company based in Cary, NC.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Heron Therapeutics Formerly VC-backed Cary, NC
Knoa Pharma Corporate Backed or Acquired Stamford, CT
Assertio Holdings Formerly VC-backed Lake Forest, IL
Collegium Pharmaceutical Formerly VC-backed Stoughton, MA
Teva Pharmaceutical Industries Corporation Tel Aviv, Israel
You’re viewing 5 of 5 competitors. Get the full list »

Maxona Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Maxona Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bleichroeder (New York) Hedge Fund Minority
To view Maxona Pharmaceuticals’s complete investors history, request access »

Maxona Pharmaceuticals FAQs

  • When was Maxona Pharmaceuticals founded?

    Maxona Pharmaceuticals was founded in 2015.

  • Where is Maxona Pharmaceuticals headquartered?

    Maxona Pharmaceuticals is headquartered in Malvern, PA.

  • What is the size of Maxona Pharmaceuticals?

    Maxona Pharmaceuticals has 1 total employees.

  • What industry is Maxona Pharmaceuticals in?

    Maxona Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Maxona Pharmaceuticals a private or public company?

    Maxona Pharmaceuticals is a Private company.

  • What is the current valuation of Maxona Pharmaceuticals?

    The current valuation of Maxona Pharmaceuticals is .

  • What is Maxona Pharmaceuticals’s current revenue?

    The current revenue for Maxona Pharmaceuticals is .

  • How much funding has Maxona Pharmaceuticals raised over time?

    Maxona Pharmaceuticals has raised $17M.

  • Who are Maxona Pharmaceuticals’s investors?

    Bleichroeder (New York) has invested in Maxona Pharmaceuticals.

  • Who are Maxona Pharmaceuticals’s competitors?

    Heron Therapeutics, Knoa Pharma, Assertio Holdings, Collegium Pharmaceutical, and Teva Pharmaceutical Industries are competitors of Maxona Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process